Insider Transactions in Q1 2023 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
526
-0.74%
|
$526
$1.78 P/Share
|
|
Mar 17
2023
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
6,999
-2.33%
|
$6,999
$1.78 P/Share
|
|
Mar 17
2023
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,808
-2.89%
|
$3,808
$1.78 P/Share
|
|
Mar 14
2023
|
Joanne M. Foody Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,750
+17.91%
|
-
|
|
Mar 14
2023
|
Benjamin Halladay Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+11.07%
|
-
|
|
Mar 14
2023
|
Sheldon L. Koenig President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105,000
+25.94%
|
-
|
|
Mar 14
2023
|
Eric Warren Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,300
+23.93%
|
-
|
|
Mar 14
2023
|
Benjamin Looker General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+19.44%
|
-
|
|
Mar 07
2023
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,884
-3.63%
|
$19,420
$5.07 P/Share
|
|
Mar 07
2023
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
5,441
-2.72%
|
$27,205
$5.06 P/Share
|
|
Mar 07
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,090
-9.49%
|
$25,450
$5.05 P/Share
|
|
Jan 18
2023
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,191
-1.1%
|
$7,146
$6.99 P/Share
|
|
Jan 18
2023
|
Benjamin Looker General Counsel |
SELL
Open market or private sale
|
Direct |
6,347
-8.96%
|
$44,429
$7.0 P/Share
|